WallStreetZenWallStreetZen

NYSE: BLND
Blend Labs Inc Stock Forecast, Predictions & Price Target

Analyst price target for BLND

Based on 3 analysts offering 12 month price targets for Blend Labs Inc.
Min Forecast
$3.00+25%
Avg Forecast
$3.20+33.33%
Max Forecast
$3.50+45.83%

Should I buy or sell BLND stock?

Based on 3 analysts offering ratings for Blend Labs Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BLND stock forecasts and price targets.

BLND stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-19
lockedlocked$00.00+00.00%2024-03-18
lockedlocked$00.00+00.00%2024-03-15
lockedlocked$00.00+00.00%2023-12-20Find Out Why

1 of 1

Forecast return on equity

Is BLND forecast to generate an efficient return?

Forecast return on assets

Is BLND forecast to generate an efficient return on assets?

BLND revenue forecast

What is BLND's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$162.1M+3.33%
Avg 2 year Forecast
$204.5M+30.4%
BLND's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BLND revenue growth forecast

How is BLND forecast to perform vs Software - Application companies and vs the US market?
Company
16.34%
Industry
15.64%
Market
9.92%
BLND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BLND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BLND vs App Stocks

TickerPricePrice TargetUp/downsideConsensus
BLND$2.40$3.20+33.33%Strong Buy
SMWB$7.71$10.75+39.43%Strong Buy
HKD$3.23N/AN/A
VMEO$3.50$4.00+14.29%Hold
MITK$12.41$19.00+53.10%Buy

Blend Labs Stock Forecast FAQ

Is Blend Labs Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: BLND) stock is to Strong Buy BLND stock.

Out of 3 analysts, 2 (66.67%) are recommending BLND as a Strong Buy, 0 (0%) are recommending BLND as a Buy, 1 (33.33%) are recommending BLND as a Hold, 0 (0%) are recommending BLND as a Sell, and 0 (0%) are recommending BLND as a Strong Sell.

If you're new to stock investing, here's how to buy Blend Labs stock.

What is BLND's revenue growth forecast for 2024-2025?

(NYSE: BLND) Blend Labs's forecast annual revenue growth rate of 16.34% is forecast to beat the US Software - Application industry's average forecast revenue growth rate of 15.64%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Blend Labs's revenue in 2024 is $156,846,000.On average, 2 Wall Street analysts forecast BLND's revenue for 2024 to be $40,850,634,543, with the lowest BLND revenue forecast at $40,151,202,115, and the highest BLND revenue forecast at $41,550,066,972.

In 2025, BLND is forecast to generate $51,550,060,342 in revenue, with the lowest revenue forecast at $49,149,305,790 and the highest revenue forecast at $53,950,814,894.

What is BLND's forecast return on assets (ROA) for 2024-2027?

(NYSE: BLND) forecast ROA is N/A, which is lower than the forecast US Software - Application industry average of N/A.

What is BLND's Price Target?

According to 3 Wall Street analysts that have issued a 1 year BLND price target, the average BLND price target is $3.20, with the highest BLND stock price forecast at $3.50 and the lowest BLND stock price forecast at $3.00.

On average, Wall Street analysts predict that Blend Labs's share price could reach $3.20 by Mar 19, 2025. The average Blend Labs stock price prediction forecasts a potential upside of 33.33% from the current BLND share price of $2.40.

What is BLND's forecast return on equity (ROE) for 2024-2027?

(NYSE: BLND) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.